Understand the source comparison
Best Peptides for Immune System Optimization: Clinical Comparison
Before selecting a peptide protocol, understand what each compound actually does. Not what marketing claims suggest. Thymosin Alpha-1 TLR activation → IL-2 upregulation T-cells (CD4+, Treg) 1.6mg subcutaneous 2x/week 4–8 weeks Gold standard for T-cell restorat
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting a peptide protocol, understand what each compound actually does. Not what marketing claims suggest.
- Thymosin Alpha-1
- TLR activation → IL-2 upregulation
- T-cells (CD4+, Treg)
- 1.6mg subcutaneous 2x/week
- 4–8 weeks
- Gold standard for T-cell restoration. Requires consistent dosing. Skipping weeks resets progress.
- LL-37
- Membrane disruption + FPRL1 signaling
- Neutrophils, epithelial cells
- 200–400mcg subcutaneous daily
- 7–14 days
- Short half-life limits practicality. Best as adjunct with vitamin D3 to boost endogenous production.
- BPC-157
- VEGF modulation + cytokine reduction
- Tissue macrophages, fibroblasts
- 250–500mcg subcutaneous daily
- Indirect immune benefit via reduced inflammation. Pairs well with Thymosin Alpha-1 for autoimmune protocols.
- Thymosin Beta-4
- Actin sequestration + wound healing
- Stem cells, endothelial cells
- 2–5mg subcutaneous 2x/week
- 10–21 days
- Primarily regenerative. Immune effects secondary to tissue repair. Less studied than Tα1 for immune-specific outcomes.
- Epitalon
- Telomerase activation (theoretical)
- All somatic cells
- 5–10mg subcutaneous 10-day cycle
- Unknown
- Mechanism controversial. No peer-reviewed RCTs demonstrate immune enhancement. Speculative use only.